BME
BlackRock Health Sciences TrustNYSE
1d
5d
1m
6m
1y
5y
10y
Advanced Chart
  • Wed, Nov. 9, 6:38 AM
    • Fears of government meddling with drug prices have apparently dissipated with Mr. Trump as President. Biotechs are ready to rally. The iShares Nasdaq Biotechnology Index Fund (NASDAQ:IBB) is up 6% premarket on increased volume.
    • ETFs: GRX, BIS, IRY, IXJ, BME, CNCR, THW, ARKG, GNRX
    | Wed, Nov. 9, 6:38 AM | 6 Comments
  • Wed, Nov. 2, 12:53 PM
    • BlackRock Resources and Commodities Strategy Trust (NYSE:BCX) - of $0.0446.
    • BlackRock Enhanced Equity Dividend Trust (NYSE:BDJ) - of $0.0467.
    • BlackRock Energy and Resources Trust (NYSE:BGR) - of $0.0776.
    • BlackRock International Growth and Income Trust (NYSE:BGY) - of $0.0380.
    • BlackRock Health Sciences Trust (NYSE:BME) - of $0.2000.
    • BlackRock Enhanced Capital and Income Fund (NYSE:CII) - of $0.0828.
    • BlackRock Global Opportunities Equity Trust (NYSE:BOE) - of $0.0780.
    • BlackRock Utility and Infrastructure Trust (NYSE:BUI) - of $0.1210.
    • BlackRock Science and Technology Trust (NYSE:BST) - of $0.1000.
    • Payable Nov. 30; for shareholders of record Nov. 15; ex-div Nov. 10.
    • Press Release
    | Wed, Nov. 2, 12:53 PM
  • Tue, Oct. 4, 7:19 AM
    • BlackRock Resources and Commodities Strategy Trust (NYSE:BCX) - of $0.0446.
    • BlackRock Enhanced Equity Dividend Trust (NYSE:BDJ) - of $0.0467.
    • BlackRock Energy and Resources Trust (NYSE:BGR) - of $0.0776.
    • BlackRock International Growth and Income Trust (NYSE:BGY) - of $0.0380.
    • BlackRock Health Sciences Trust (NYSE:BME) - of $0.2000.
    • BlackRock Enhanced Capital and Income Fund (NYSE:CII) - of $0.0828.
    • BlackRock Global Opportunities Equity Trust (NYSE:BOE) - of $0.0780.
    • BlackRock Utility and Infrastructure Trust (NYSE:BUI) - of $0.1210.
    • BlackRock Science and Technology Trust (NYSE:BST) - of $0.1000.
    • Payable Oct. 31; for shareholders of record Oct. 14; ex-div Oct. 12.
    • Press Release
    | Tue, Oct. 4, 7:19 AM | 2 Comments
  • Tue, Sep. 13, 8:02 AM
    • BlackRock Resources and Commodities Strategy Trust (NYSE:BCX) distribution of $0.0446.
    • BlackRock Enhanced Equity Dividend Trust (NYSE:BDJ) distribution of $0.0467.
    • BlackRock Energy and Resources Trust (NYSE:BGR) distribution of $0.0776.
    • BlackRock International Growth and Income Trust (NYSE:BGY) distribution of $0.0380.
    • BlackRock Health Sciences Trust (NYSE:BME) distribution of $0.2000.
    • BlackRock Enhanced Capital and Income Fund (NYSE:CII) distribution of $0.1000.
    • BlackRock Global Opportunities Equity Trust (NYSE:BOE) distribution of $0.0780.
    • BlackRock Utility and Infrastructure Trust (NYSE:BUI) distribution of $0.1210.
    • BlackRock Science and Technology Trust (NYSE:BST) distribution of $0.1000.
    • Payable Sept. 30; for shareholders of record Sept. 15; ex-div Sept. 13.
    • Press Release
    | Tue, Sep. 13, 8:02 AM | 1 Comment
  • Thu, Aug. 11, 1:48 PM
    • BlackRock Resources and Commodities Strategy Trust (NYSE:BCX) distribution of $0.0446.
    • BlackRock Enhanced Equity Dividend Trust (NYSE:BDJ) distribution of $0.0467.
    • BlackRock Energy and Resources Trust (NYSE:BGR) distribution of $0.0776.
    • BlackRock International Growth and Income Trust (NYSE:BGY) distribution of $0.0380.
    • BlackRock Health Sciences Trust (NYSE:BME) distribution of $0.2000.
    • BlackRock Enhanced Capital and Income Fund (NYSE:CII) distribution of $0.1000.
    • BlackRock Global Opportunities Equity Trust (NYSE:BOE) distribution of $0.0780.
    • BlackRock Utility and Infrastructure Trust (NYSE:BUI) distribution of $0.1210.
    • BlackRock Science and Technology Trust (NYSE:BST) distribution of $0.1000.
    • Payable Aug. 31; for shareholders of record Aug. 15; ex-div Aug. 11.
    • Press Release
    | Thu, Aug. 11, 1:48 PM
  • Mon, Jul. 11, 1:14 PM
    • BlackRock Resources and Commodities Strategy Trust (NYSE:BCX) distribution of $0.0446.
    • BlackRock Enhanced Equity Dividend Trust (NYSE:BDJ) distribution of $0.0467.
    • BlackRock Energy and Resources Trust (NYSE:BGR) distribution of $0.0776.
    • BlackRock International Growth and Income Trust (NYSE:BGY) distribution of $0.0380.
    • BlackRock Health Sciences Trust (NYSE:BME) distribution of $0.2000.
    • BlackRock Enhanced Capital and Income Fund (NYSE:CII) distribution of $0.1000.
    • BlackRock Global Opportunities Equity Trust (NYSE:BOE) distribution of $0.0780.
    • BlackRock Utility and Infrastructure Trust (NYSE:BUI) distribution of $0.1210.
    • BlackRock Science and Technology Trust (NYSE:BST) distribution of $0.1000.
    • Payable July 29; for shareholders of record July 15; ex-div July 13.
    • Press Release
    | Mon, Jul. 11, 1:14 PM
  • Thu, Jun. 9, 11:13 AM
    • The FDA, along with international regulatory and law enforcement agencies in an initiative called Operation Pangea IX, took action against 4,402 websites engaged in the illegal selling of unapproved prescription drugs to U.S. consumers. The operation was part of a global coordinated effort led by INTERPOL called IIWA to stop the sale and distribution of illegal and potentially counterfeit medications on the internet.
    • The goal of Operation Pangea IX was to identify the manufacturers and distributors of the illegal meds and to remove the products from the supply chain. The FDA's enforcement action, which ran from May 31 to June 7, included formal complaints to domain registrars requesting the suspension of 4,402 websites, including 110 sites that sell 2,4-Dinitrophenol (DNP), typically used as a dye, wood preserver and herbicide, but never approved in the U.S. as a drug.
    • The FDA has been investigating the distribution of DNP for some time. Last month, a Bakersfield, CA man pleaded guilty to interstate commerce of an unapproved drug based on the work by an agency task force. In 2013, one of his DNP customers died after ingesting it.
    • ETFs: GRX, IRY, IXJ, BME, THW, GNRX
    | Thu, Jun. 9, 11:13 AM | 2 Comments
  • Tue, Jun. 7, 1:11 PM
    • BlackRock Resources and Commodities Strategy Trust (NYSE:BCX) distribution of $0.0446.
    • BlackRock Enhanced Equity Dividend Trust (NYSE:BDJ) distribution of $0.0467.
    • BlackRock Energy and Resources Trust (NYSE:BGR) distribution of $0.0776.
    • BlackRock International Growth and Income Trust (NYSE:BGY) distribution of $0.0490.
    • BlackRock Health Sciences Trust (NYSE:BME) distribution of $0.2000.
    • BlackRock Enhanced Capital and Income Fund (NYSE:CII) distribution of $0.1000.
    • BlackRock Global Opportunities Equity Trust (NYSE:BOE) distribution of $0.0970.
    • BlackRock Utility and Infrastructure Trust (NYSE:BUI) distribution of $0.1210.
    • BlackRock Science and Technology Trust (NYSE:BST) distribution of $0.1000.
    • Payable June 30; for shareholders of record June 15; ex-div June 13.
    | Tue, Jun. 7, 1:11 PM | 1 Comment
  • Thu, May 12, 12:51 PM
    • BlackRock Resources and Commodities Strategy Trust (NYSE:BCX) announces monthly distribution of $0.0446.
    • BlackRock Enhanced Equity Dividend Trust (NYSE:BDJ) announces monthly distribution of $0.0467.
    • BlackRock Energy and Resources Trust (NYSE:BGR) announces monthly distribution of $0.0776.
    • BlackRock International Growth and Income Trust (NYSE:BGY) announces monthly distribution of $0.0490.
    • BlackRock Health Sciences Trust (NYSE:BME) announces monthly distribution of $0.2000.
    • BlackRock Enhanced Capital and Income Fund (NYSE:CII) announces monthly distribution of $0.1000.
    • BlackRock Global Opportunities Equity Trust (NYSE:BOE) announces monthly distribution of $0.0970.
    • BlackRock Utility and Infrastructure Trust (NYSE:BUI) announces monthly distribution of $0.1210.
    • BlackRock Science and Technology Trust (NYSE:BST) announces monthly distribution of $0.1000.
    • Payable May 31; for shareholders of record May 16; ex-div May 12.
    | Thu, May 12, 12:51 PM | 3 Comments
  • Tue, Apr. 12, 6:17 PM
    • BlackRock declares dividend on Equity Funds BlackRock Resources and Commodities Strategy Trust (NYSE:BCX) announces monthly distribution of $0.0446.
    • BlackRock Enhanced Equity Dividend Trust (NYSE:BDJ) announces monthly distribution of $0.0467.
    • BlackRock Energy and Resources Trust (NYSE:BGR) announces monthly distribution of $0.0776.
    • BlackRock International Growth and Income Trust (NYSE:BGY) announces monthly distribution of $0.0490.
    • BlackRock Health Sciences Trust (NYSE:BME) announces monthly distribution of $0.2000.
    • BlackRock Enhanced Capital and Income Fund (NYSE:CII) announces monthly distribution of $0.1000.
    • BlackRock Global Opportunities Equity Trust (NYSE:BOE) announces monthly distribution of $0.0970.
    • BlackRock Utility and Infrastructure Trust (NYSE:BUI) announces monthly distribution of $0.1210.
    • BlackRock Science and Technology Trust (NYSE:BST) announces monthly distribution of $0.1000.
    • Payable Apr 29; for shareholders of record Apr 15; ex-div Apr. 13.
    | Tue, Apr. 12, 6:17 PM
  • Fri, Mar. 11, 12:17 PM
    | Fri, Mar. 11, 12:17 PM
  • Thu, Feb. 11, 12:22 PM
    | Thu, Feb. 11, 12:22 PM
  • Wed, Jan. 20, 12:03 PM
    • Even critics of Roche's (OTCQX:RHHBY -2.1%) consistent opposition to the off-label use of cancer med Avastin (bevacizumab) for wet age-related macular degeneration (wet AMD) instead of the pricier Lucentis (ranibizumab) now must concede that its view is credible as it relates to patient safety.
    • In cost conscious India, two states have suspended sales of Avastin after 15 wet AMD patients experienced pain and swelling in their eyes after receiving the medication. The company's India unit stands behind the drug while emphasizing that it does not promote Avastin for unapproved uses which, of course, have not been satisfactorily vetted via clinical trials.
    • A number of countries in Europe have been receptive to the off-label use of Avastin for wet AMD considering Lucentis is 30x more expensive. France, for example, would save the equivalent of $273M each year by switching.
    • Manufacturers have fought back. In September, an industry group filed a complaint with the European Commission arguing that French regulators' approval of Avastin for wet AMD is contrary to the EU approval process for medicines and "puts patients' health at risk."
    • The differing cost/benefit viewpoints will, no doubt, persist indefinitely as more and more expensive biologics reach the market.
    • ETFs: BIB, GRX, IRY, BIS, IXJ, BME, CNCR, THW
    | Wed, Jan. 20, 12:03 PM | 1 Comment
  • Thu, Jan. 14, 10:57 AM
    • Biotechs are moving in sync with the market today. The iShares Nasdaq Biotech Index Fund (IBB +1.8%) is up ~4% from its low of 273.47, outpacing the Nasdaq Composite's 2.6% jump from its intraday low of 4,470.59. The IBB had lost over 20% of its value since late December.
    • ETFs: BIB, GRX, IRY, BIS, IXJ, BME, CNCR, THW
    | Thu, Jan. 14, 10:57 AM | 2 Comments
  • Tue, Jan. 12, 12:53 PM
    | Tue, Jan. 12, 12:53 PM
  • Tue, Jan. 12, 11:26 AM
    • The FDA approved 45 new drugs in 2015, second only to 1996's 53. 16 (36%) were first-in-class treatments and 21 (47%) were for rare diseases.
    • Among the new molecular entities cleared last year were Novartis' Cosentyx (secukinumab) for psoriasis, Farydak (panobinostat) for multiple myeloma and Entresto (sacubitril/valsartan) for heart failure, Pfizer's Ibrance (palbociclib) for breast cancer, Sanofi/Regeneron's Praluent and Amgen's Repatha for lowering cholesterol and Eli Lilly's Portrazza (necitumumab) for lung cancer.
    • 2016 should be another strong year for drug approvals, stoked by the FDA's accelerated review designations: Fast Track, Breakthrough Therapy and Priority Review.
    • ETFs: BIB, GRX, IRY, BIS, IXJ, BME, CNCR, THW
    | Tue, Jan. 12, 11:26 AM